Crispr Therapeutics Ag (CRSP)

Jan 19, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Short Interest Up 5.4% in December - MarketBeat

Jan 19, 2025

Jan 19, 2025

Gene Editing Market Overview and Leading Players: Horizon - openPR

Jan 19, 2025

Jan 18, 2025

Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia - Benzinga

Jan 18, 2025

Jan 17, 2025

CRISPR Therapeutics Stock Falls 34% in a Year: Time to Buy or Sell? - MSN

Jan 17, 2025

Jan 17, 2025

CRISPR Therapeutics AG (CRSP): The Biotech Stock with Biggest Upside Potential - Insider Monkey

Jan 17, 2025

Jan 17, 2025

CRISPR Therapeutics' SWOT analysis: gene editing pioneer's stock faces pivotal year - Investing.com India

Jan 17, 2025

Jan 17, 2025

12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey

Jan 17, 2025

Jan 17, 2025

7,536 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Purchased by Mirador Capital Partners LP - MarketBeat

Jan 17, 2025

Jan 16, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Jan 16, 2025

Jan 16, 2025

Vertex's Pain Drug: Big Pharma's Next Major Success? - Benzinga

Jan 16, 2025

Jan 16, 2025

My 10 Top Stocks to Buy to Start the New Year Off Right - The Motley Fool

Jan 16, 2025

Jan 15, 2025

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers - Seeking Alpha

Jan 15, 2025

Jan 15, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 1-Year LowTime to Sell? - MarketBeat

Jan 15, 2025

Jan 15, 2025

Genome Engineering Market Is Booming Worldwide 2024-2031 | Thermo Fisher Scientific Inc., CRISPR Therapeutics - EIN News

Jan 15, 2025

Jan 14, 2025

CRISPR Therapeutics' (CRSP) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Jan 14, 2025

Jan 14, 2025

How to Take Advantage of moves in (CRSP) - Stock Traders Daily

Jan 14, 2025

Jan 13, 2025

CRISPR Therapeutics outlines 2025 strategic goals By Investing.com - Investing.com Canada

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month LowWhat's Next? - MarketBeat

Jan 13, 2025

Jan 13, 2025

CRISPR-based Gene Editing Market Report 2025, with Company Profiles of the Top 10+ Major Market Players - Yahoo Finance UK

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics stock hits 52-week low at $38.2 - Investing.com India

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics stock hits 52-week low at $38.2 By Investing.com - Investing.com Nigeria

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics outlines 2025 strategic goals - Investing.com India

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2025 Milestones - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics (CRSP) Highlights Strategic Priorities and Anticipated 2025 Milestones - StreetInsider.com

Jan 13, 2025

Jan 13, 2025

CRISPR Therapeutics Reveals 2025 Pipeline Plans: CASGEVY Success Drives $1.9B Cash Position - StockTitan

Jan 13, 2025

Jan 12, 2025

Catherine Wood's Recent Transaction with CRISPR Therapeutics AG - GuruFocus.com

Jan 12, 2025

Jan 09, 2025

Brookline Capital Management Estimates CRSP FY2024 Earnings - MarketBeat

Jan 09, 2025

Jan 08, 2025

Equities Analysts Issue Forecasts for CRSP FY2029 Earnings - MarketBeat

Jan 08, 2025

Jan 08, 2025

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025

Jan 08, 2025

Interesting CRSP Put And Call Options For February 28th - Nasdaq

Jan 08, 2025

Jan 07, 2025

CRISPR Therapeutics to add Briggs Morrison to Board By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note - MSN

Jan 07, 2025

Jan 07, 2025

Bank of America Lowers CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $85.00 - MarketBeat

Jan 07, 2025

Jan 07, 2025

2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025 - MarketBeat

Jan 07, 2025

Jan 07, 2025

CRISPR Therapeutics to add Briggs Morrison to Board - Investing.com

Jan 07, 2025

Jan 07, 2025

Intellia Thera CS (NTLA-Q) QuotePress Release - The Globe and Mail

Jan 07, 2025

Jan 07, 2025

CRISPR Therapeutics Proposes New Appointment to the Board of Directors - GlobeNewswire

Jan 07, 2025

Jan 07, 2025

CRISPR Therapeutics Strengthens Board with Former AstraZeneca Clinical Development Leader - StockTitan

Jan 07, 2025

Jan 06, 2025

Check Out What Whales Are Doing With CRSP - Benzinga

Jan 06, 2025

Jan 06, 2025

Capital Market Strategies LLC Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jan 06, 2025

Jan 03, 2025

How To Trade (CRSP) - Stock Traders Daily

Jan 03, 2025

Jan 02, 2025

Top 5 CRISPR Companies To Invest In (January 2025) - Securities.io

Jan 02, 2025

Jan 01, 2025

CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know - MSN

Jan 01, 2025

Dec 31, 2024

CRISPR Therapeutics AG's (NASDAQ:CRSP) Share Price Not Quite Adding Up - Simply Wall St

Dec 31, 2024

Dec 31, 2024

CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to Sell Rating - MarketBeat

Dec 31, 2024

Dec 30, 2024

Why Is CRISPR Therapeutics AG (CRSP) Among the Top CRISPR Stocks to Invest In? - Insider Monkey

Dec 30, 2024

Dec 30, 2024

Top 11 CRISPR Stocks to Invest In - Insider Monkey

Dec 30, 2024

Dec 30, 2024

CRISPR Therapeutics (NASDAQ:CRSP) Reaches New 52-Week LowWhat's Next? - MarketBeat

Dec 30, 2024

Dec 30, 2024

CRISPR Therapeutics stock hits 52-week low at $39.31 By Investing.com - Investing.com Nigeria

Dec 30, 2024

Dec 30, 2024

CRISPR Therapeutics stock hits 52-week low at $39.31 - Investing.com

Dec 30, 2024